Novo Nordisk CEO Concedes Eli Lilly’s Market-Share Gains as Stock Slumps

Novo Nordisk's CEO conceded Eli Lilly is gaining market share even as oral Wegovy hits record prescriptions and the stock keeps falling. The post Novo Nordisk CEO Concedes Eli Lilly’s Market-Share Gains as Stock Slumps appeared first on BeInCrypto.